AAAAAA
Results:
1-19
|
Results: 19
Authors:
Muller, DN
Heissmeyer, V
Dechend, R
Hampich, F
Park, JK
Fiebeler, A
Shagdarsuren, E
Theuer, J
Elger, M
Pilz, B
Breu, V
Schroer, K
Ganten, D
Dietz, R
Haller, H
Scheidereit, C
Luft, FC
Citation: Dn. Muller et al., Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organdamage, FASEB J, 15(8), 2001, pp. NIL_117-NIL_135
Authors:
Fiebeler, A
Schmidt, F
Muller, DN
Park, JK
Dechend, R
Bieringer, M
Shagdarsuren, E
Breu, V
Haller, H
Luft, FC
Citation: A. Fiebeler et al., Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-Induced cardiac injury, HYPERTENSIO, 37(2), 2001, pp. 787-793
Authors:
Muller, DN
Mervaala, EMA
Schmidt, F
Park, JK
Dechend, R
Genersch, E
Breu, V
Loffler, BM
Ganten, D
Schneider, W
Haller, H
Luft, FC
Citation: Dn. Muller et al., Effect of bosentan on NF-kappa B, inflammation, and tissue factor in angiotensin II-induced end-organ damage, HYPERTENSIO, 36(2), 2000, pp. 282-290
Authors:
Mervaala, E
Muller, DN
Schmidt, F
Park, JK
Gross, V
Bader, M
Breu, V
Ganten, D
Haller, H
Luft, FC
Citation: E. Mervaala et al., Blood pressure-independent effects in rats with human renin and angiotensinogen genes, HYPERTENSIO, 35(2), 2000, pp. 587-594
Authors:
Muller, DN
Dechend, R
Mervaala, EMA
Park, JK
Schmidt, F
Fiebeler, A
Theuer, J
Breu, V
Ganten, D
Haller, H
Luft, FC
Citation: Dn. Muller et al., NF-kappa B inhibition ameliorates angiotensin II-induced inflammatory damage in rats, HYPERTENSIO, 35(1), 2000, pp. 193-201
Authors:
Mervaala, E
Muller, DN
Park, JK
Dechend, R
Schmidt, F
Fiebeler, A
Bieringer, M
Breu, V
Ganten, D
Haller, H
Luft, FC
Citation: E. Mervaala et al., Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes, HYPERTENSIO, 35(1), 2000, pp. 360-366
Authors:
Schauer-Vukasinovic, V
Wright, MB
Breu, V
Giller, T
Citation: V. Schauer-vukasinovic et al., Cloning, expression and functional characterization of rat napsin, BBA-GENE ST, 1492(1), 2000, pp. 207-210
Authors:
Muller, DN
Mervaala, EMA
Dechend, R
Fiebeler, A
Park, JK
Schmidt, F
Theuer, J
Breu, V
Mackman, N
Luther, T
Schneider, W
Gulba, D
Ganten, D
Haller, H
Luft, FC
Citation: Dn. Muller et al., Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor inangiotensin II-induced cardiac vasculopathy, AM J PATH, 157(1), 2000, pp. 111-122
Authors:
Scommotau, S
Uhlmann, D
Loffler, BM
Breu, V
Spiegel, HU
Citation: S. Scommotau et al., Involvement of endothelin nitric oxide balance in hepatic ischemia reperfusion injury, LANG ARCH S, 384(1), 1999, pp. 65-70
Authors:
Oefner, C
Binggeli, A
Breu, V
Bur, D
Clozel, JP
D'Arcy, A
Dorn, A
Fischli, W
Gruninger, F
Guller, R
Hirth, G
Marki, HP
Mathews, S
Muller, M
Ridley, RG
Stadler, H
Vieira, E
Wilhelm, M
Winkler, FK
Wostl, W
Citation: C. Oefner et al., Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?, CHEM BIOL, 6(3), 1999, pp. 127-131
Authors:
Vieira, E
Binggeli, A
Breu, V
Bur, D
Fischli, W
Guller, R
Hirth, G
Marki, HP
Muller, M
Oefner, C
Scalone, M
Stadler, H
Wilhelm, M
Wostl, W
Citation: E. Vieira et al., Substituted piperidines - Highly potent renin inhibitors due to induced fit adaptation of the active site, BIOORG MED, 9(10), 1999, pp. 1397-1402
Authors:
Guller, R
Binggeli, A
Breu, V
Bur, D
Fischli, W
Hirth, G
Jenny, C
Kansy, M
Montavon, F
Muller, M
Oefner, C
Stadler, H
Vieira, E
Wilhelm, M
Wostl, W
Marki, HP
Citation: R. Guller et al., Piperidine-renin inhibitors compounds with improved physicochemical properties, BIOORG MED, 9(10), 1999, pp. 1403-1408
Authors:
Roux, S
Breu, V
Ertel, SI
Clozel, M
Citation: S. Roux et al., Endothelin antagonism with bosentan: a review of potential applications, J MOL MED-J, 77(4), 1999, pp. 364-376
Authors:
Luft, FC
Mervaala, E
Muller, DN
Gross, V
Schmidt, F
Park, JK
Schmitz, C
Lippoldt, A
Breu, V
Dechend, R
Dragun, D
Schneider, W
Ganten, D
Haller, H
Citation: Fc. Luft et al., Hypertension-induced end-organ damage - A new transgenic approach to an old problem, HYPERTENSIO, 33(1), 1999, pp. 212-218
Authors:
Muller, DN
Hilgers, KF
Mathews, S
Breu, V
Fischli, W
Uhlmann, R
Luft, FC
Citation: Dn. Muller et al., Effects of human prorenin in rats transgenic for human angiotensinogen, HYPERTENSIO, 33(1), 1999, pp. 312-317
Authors:
Mervaala, EMA
Muller, DN
Park, JK
Schmidt, F
Lohn, M
Breu, V
Dragun, D
Ganten, D
Haller, H
Luft, FC
Citation: Ema. Mervaala et al., Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension, HYPERTENSIO, 33(1), 1999, pp. 389-395
Authors:
Valdenaire, O
Breu, V
Giller, T
Bur, D
Fischli, W
Citation: O. Valdenaire et al., Cloning and characterization of marmoset renin: Comparison with human renin, J CARDIO PH, 34(6), 1999, pp. 893-897
Authors:
Clozel, M
Ramuz, H
Clozel, JP
Breu, V
Hess, P
Loffler, BM
Coassolo, P
Roux, S
Citation: M. Clozel et al., Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use, J PHARM EXP, 290(2), 1999, pp. 840-846
Authors:
Pieske, B
Beyermann, B
Breu, V
Loffler, BM
Schlotthauer, K
Maier, LS
Schmidt-Schweda, S
Just, H
Hasenfuss, G
Citation: B. Pieske et al., Functional effects of endothelin and regulation of endothelin receptors inisolated human nonfailing and failing myocardium, CIRCULATION, 99(14), 1999, pp. 1802-1809
Risultati:
1-19
|